Cancer u-turn reveals division in PMI

hospital-patient

Bupa’s u-turn on capping cancer cover for its corporate schemes has exposed how fragmented 
the private medical insurance (PMI) industry is in its approach to the disease.

The healthcare giant claimed the recent policy reversal was an industry first and admitted that experience had shown that capping cancer cover left patients who claimed on their policies vulnerable at critical points in their treatment.

Bupa first removed cancer cover from its Select policy for schemes with more than 50 employees in November 2009 and, at the time, the insurer argued that the option gave customers choice.

Dr Natalie-Jane Macdonald, managing director, Bupa Health and Wellbeing

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@insuranceage.co.uk.

You are currently unable to copy this content. Please contact info@insuranceage.co.uk to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Insurance Age? View our subscription options

Register

Sign up and gain access to five complimentary news articles every month.

Already have an account? Sign in here

Most read articles loading...

You need to sign in to use this feature. If you don’t have an Insurance Age account, please register now.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: